The recent report from the American Academy of Ophthalmology makes a compelling case for selecting Selective Laser Trabeculoplasty (SLT) as a preferred first-line treatment for primary open-angle glaucoma (POAG). As shown in the LiGHT trial, SLT is not only effective but significantly reduces disease progression risk when compared to topical medications. Findings of this study combine data from over 6 years of research and analysis. For more, check out this full article of the AAO report.
Why SLT is Gaining Ground.
SLT brings considerable benefits for patients who struggle with long-term medication adherence, side effects, or the costs associated with prescription eye drops. SLT has shown measurable, reliable results in IOP reduction. For glaucoma specialists, this adds a layer of predictability and patient-centered benefit that topical medications alone may not provide. In addition to its efficacy, SLT addresses critical challenges in managing long-term patient care. As a repeatable and low-risk laser procedure, it offers a targeted, consistent approach to lowering IOP, minimizing both the variation and patient compliance issues associated with daily eye drops. In cases where the patient is unable to maintain the strict daily regimen of topical medication, SLT can bridge that gap and provide consistent IOP reduction without the daily burden on the patient.
Beyond adherence, the study highlighted SLT’s potential to reduce the need for additional treatments in the long term, potentially delaying or even reducing the need for surgical intervention as the disease progresses. This is significant for patients, as glaucoma’s slow progression means every delay in treatment escalation can contribute to preserving their vision for a longer period. SLT’s repeatability also ensures that, should additional IOP reduction be necessary, this option remains available for re-treatment, providing a flexible approach to patient care.
Flexible SLT Laser Access with Surgical Direct
At Surgical Direct, we recognize the value SLT brings to glaucoma management, and we’re here to help you incorporate it into your practice effortlessly. Whether you’re scaling access across multiple locations or establishing a single-day SLT treatment, our service model is designed to be as adaptable as possible.
We offer SLT laser rentals with flexible half-day or full-day options to fit seamlessly into your schedule, ensuring you have the latest equipment when and where you need it…without the capital investment.
If you’ve been considering offering SLT as a first-line glaucoma treatment, and want a turn-key (easy) option, start a conversation with us today!
Surgical Direct is the partnership that you’ve been looking for.
